Gross Profit: Revenues from operations less the associated costs.
Silo Pharma, Inc. (SILO) had Gross Profit of $-0.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.02M |
|
$-0.88M |
|
$0.02M |
|
|
Gross Profit |
$-0.00M |
$0.80M |
|
$-0.79M |
|
$-0.10M |
|
$-0.88M |
|
$-0.88M |
|
$-0.88M |
|
$-0.88M |
|
$-0.88M |
|
$-0.88M |
|
$-0.79M |
|
$-0.78M |
|
8.38M |
|
8.38M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$7.39M |
|
-- |
|
$0.22M |
|
$7.61M |
|
$0.65M |
|
-- |
|
$0.65M |
|
$1.30M |
|
$6.31M |
|
$6.09M |
|
$6.31M |
|
13.32M |
|
| Cash Flow Statement Financials | |
$-4.66M |
|
$0.64M |
|
$4.86M |
|
$3.91M |
|
$4.75M |
|
$0.84M |
|
$0.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.77% |
|
-4363.27% |
|
-4363.27% |
|
-- |
|
-4890.32% |
|
-4890.32% |
|
$-4.66M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-13.98% |
|
-14.48% |
|
-11.59% |
|
-13.98% |
|
$0.47 |
|
$-0.56 |
|
$-0.56 |
|